Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial
Source: Neuropsychiatric Disease and Treatment - Category: Psychiatry Tags: Neuropsychiatric Disease and Treatment Source Type: research
More News: Anxiety | Brain | Depression | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Eyes | Fluoxetine | Neurology | Prozac | Psychiatry